The circulatory half-lives of α-profibrin and α-fibrin monomer, and comparisons with other fibrin(ogen) derivatives

Thrombosis and Haemostasis

Volumn 89, Issue 1, 2003, Pages 48-52

  Shainoff, John R ^a   DiBello, Patricia M ^a  

^a CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Clearance; Fibrinogen; Fibrin; Profibrin

Indexed keywords

ALPHA FIBRIN MONOMER; ALPHA PROFIBRIN MONOMER; FIBRIN DERIVATIVE; FIBRIN MONOMER; FIBRINOGEN; FIBRINOPEPTIDE; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; CALCULATION; CIRCULATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRAVASCULAR SPACE; FIBRIN CLOT; HUMAN CELL; NONHUMAN; PLASMA CLEARANCE; PLASMA HALF LIFE; PLOTS AND CURVES; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RABBIT; RECEPTOR BINDING; VASCULAR DISEASE;

EID: 0037250480     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613542     Document Type: Article

References (24)

1. Dardik BN, Shainoff JR. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer. Blood 1985; 65: 680-8.
2. Shainoff JR, Dardik BN. Effects of cross-linking on clearance of circulating α-fibrin monomer and its complexes. J Lab Clin Med 1990; 115: 314-23.
3. Shainoff JR, Gonda SR. Adsorptive endocytosis of fibrin monomer by macrophages: Evidence of a receptor for the amino terminus of the fibrin α-chain. Proc Natl Acad Sci USA 1982; 79: 4565-9.
4. Shainoff JR, Stearns DJ, DiBello PM, Hishikawa-Itoh Y. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines. Thromb Haemost 1990; 60: 193-203.
5. Shainoff JR, Smejkal GB, DiBello PM, Chase B, Mitkevich OV, Lill H. The fibrin intermediate, its place in the fibrinogen-fibrin transformation. Ann NY Acad Sci 2001; 936: 147-66.
6. Shainoff JR, DiBello PM. Fibrin precursors, intermediaries for hemostasis in the clot war. Thromb Res 2002; 105: 3-13.
7. Shainoff JR, Page IH. Cofibrins and fibrin intermediates as indicators of thrombin activity in vivo. Circ Res 1960; 8: 1013-22.
8. Shainoff JR, Page IH. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med 1962; 116: 687-707.
9. Shainoff JR, Smejkal GB, DiBello PM, Sung SS, Bush LA, DiCera E. Allosteric effects potentiating the release of the second fibrinopeptide A from fibrinogen by thrombin. J Biol Chem 2002; 277: 19367-73.
10. Shainoff JR, Urbanic DA, DiBello PM, Valenzuela V. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood. Blood Coagul Fibrinolysis 1993; 4: 87-92.
11. Shainoff JR, Smejkal GB, DiBello PM, Mitkevich OV, Levy PJ, Lill H et al. Isolation and characterization of the fibrin-intermediate arising from cleavage of one fibrinopeptide A from fibrinogen. J Biol Chem 1996; 271: 24129-37.
12. Kanaide H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor. J Lab Clin Med 1975; 85: 574-97.
13. Atencio AC, Reeve EB. Studies on the metabolism and distribution of fibrinogen in young and older rabbit. II. Results. J Lab Clin Med 1965; 66: 20-33.
14. Yang Z, Kollman JM, Pandi L, Doolittle RF. Crystal structure of native chicken fibrinogen at 2.7 A resolution. Biochem 2001, 40: 12515-23.
15. Dempfle CE. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state. Thromb Haemost 1999; 82: 673-83.
16. Nieuwenhuizen W. Soluble fibrin as a molecular marker for a pre-thrombotic state: A mini-review. Blood Coagul Fibrinolysis 1993; 4: 93-6.
17. Schwartz ML, Pizzo SV, Hill RL, McKee PA. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. J Clin Invest 1971; 50: 1506-13.
18. Rjagopalan S, Pizzo SV. Characterization of murine peritoneal macrophage receptors for fibrino(oge) degradation products. Blood 1986; 67: 1224-8.
19. Pasqua JJ, Pizzo SV. The clearance of human fibrinogen fragments X and Y in mice: A process mediated by the fragment D receptor. Thromb Haemost 1983; 49: 78-80.
20. Pasqua JJ, Pizzo SV. The role of ligand-ligand interactions in competition by fibrinogen and fibrin degradation products for fibrinogen binding to human platelets. Biochim Biophys Acta 1983; 757: 282-7.
21. Pizzo SV, Pasqua JJ. The clearance of human fibrinogen fragments D1, D2, D3 and fibrin fragment D1 dimer in mice. Biochim Biophys Acta 1982; 718: 177-84.
22. Catanzaro A, Edgington TS. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin. J Lab Clin Med 1974; 83: 458-66.
23. Brommer EJP, Engbers J, Laarse AVd, Nieuwenhuizen W. Survival of fibrinogen degradation products in the circulation after thrombolytic therapy for acute myocardial infarction. Fibrinolysis 1988; 1: 149-53.
24. Olexa SA, Budzynski AZ. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin. J Biol Chem 1979; 254: 4925-32.